CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | tunicamycin B1 |
|
Accession: | CHEBI:64248
|
browse the term
|
Definition: | A nucleoside that is one of the homologues in the mixture that is tunicamycin, characterised by a pentadec-2-enoyl fatty acyl substituent on the amino group of the tunicamine moiety. |
Synonyms: | exact_synonym: | (2E)-N-[(2S,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-6-{(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-2-hydroxyethyl}-4,5-dihydroxytetrahydro-2H-pyran-3-yl]pentadec-2-enamide; (5'R)-5'-[2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1<->1)-2,6-dideoxy-2-(pentadec-2-enamido)-beta-D-galactopyranos-6-yl]uridine |
| related_synonym: | Formula=C38H62N4O16; InChI=1S/C38H62N4O16/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-24(46)40-27-31(51)28(48)22(55-37(27)58-36-26(39-20(2)44)30(50)29(49)23(19-43)56-36)18-21(45)34-32(52)33(53)35(57-34)42-17-16-25(47)41-38(42)54/h14-17,21-23,26-37,43,45,48-53H,3-13,18-19H2,1-2H3,(H,39,44)(H,40,46)(H,41,47,54)/b15-14+/t21-,22-,23-,26-,27-,28+,29-,30-,31-,32+,33-,34-,35-,36-,37+/m1/s1; InChIKey=QYVMTFXNKNWWFX-YGTZKZKGSA-N; SMILES=[H][C@@](O)(C[C@H]1O[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@H](NC(=O)\\C=C\\CCCCCCCCCCCC)[C@@H](O)[C@H]1O)[C@@]1([H])O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O; tunicamycin IV |
| xref: | PMID:7061468 |
|
|
|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AARS1 mRNA; Tunicamycin results in increased expression of AARS1 protein |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Aarsd1 |
alanyl-tRNA synthetase domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AARSD1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:86,340,625...86,353,732
Ensembl chr10:86,340,626...86,353,729
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression decreases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of ABCB1 mRNA Tunicamycin results in decreased expression of ABCB1 protein 1-(4-chlorophenyl)-3-(3-(4-chlorophenyl)-5,5-dimethyl-1-(3-(5-nitrofuran-2-yl)allyldienehydrazinocarbonylmethyl)-2-oxoimidazolidin-4-yl)-1-hydroxyurea inhibits the reaction [Tunicamycin results in decreased expression of ABCB1 protein] |
CTD |
PMID:29453283 PMID:34915026 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCB1B mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb7 |
ATP binding cassette subfamily B member 7 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCB7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCC1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ABCC3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCE1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
|
|
G |
Abitram |
actin binding transcription modulator |
increases expression |
ISO |
Tunicamycin results in increased expression of ABITRAM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:71,505,848...71,524,224
Ensembl chr 5:71,505,813...71,511,890
|
|
G |
Abtb1 |
ankyrin repeat and BTB domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABTB1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACAA2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of ACACA mRNA Tunicamycin results in decreased expression of ACACA mRNA |
CTD |
PMID:22378314 PMID:22414386 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACACB mRNA |
CTD |
PMID:17127020 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acad10 |
acyl-CoA dehydrogenase family, member 10 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACAD10 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACAD11 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACAD9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
increases expression |
ISO |
Tunicamycin results in increased expression of ACADVL mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
decreases expression decreases expression multiple interactions |
ISO |
Tunicamycin results in decreased expression of ACAT1 mRNA tunicamycin decreases expression of Acat1 mRNA in liver naltrexone inhibits the reaction [tunicamycin decreases expression of Acat1 mRNA in liver] |
CTD RGD |
PMID:22378314 PMID:27813192 PMID:27813192 |
RGD:401842386, RGD:401842386 |
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACAT2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acbd3 |
acyl-CoA binding domain containing 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACBD3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:92,455,813...92,484,556
Ensembl chr13:92,455,655...92,483,380
|
|
G |
Acer3 |
alkaline ceramidase 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACER3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
|
|
G |
Acly |
ATP citrate lyase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACLY mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acot13 |
acyl-CoA thioesterase 13 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACOT13 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
|
|
G |
Acot7 |
acyl-CoA thioesterase 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACOT7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACOX1 mRNA |
CTD |
PMID:22414386 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acp6 |
acid phosphatase 6, lysophosphatidic |
increases expression |
ISO |
Tunicamycin results in increased expression of ACP6 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:184,711,975...184,733,067
Ensembl chr 2:184,711,619...184,733,017
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACSL5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
ISO |
Tunicamycin results in increased expression of ACTA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACTB mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actg1 |
actin, gamma 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACTG1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
|
|
G |
Acvr1 |
activin A receptor type 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACVR1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
|
|
G |
Acvr1c |
activin A receptor type 1C |
increases expression |
ISO |
Tunicamycin results in increased expression of ACVR1C mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACY1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam23 |
ADAM metallopeptidase domain 23 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADAM23 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:64,862,649...65,009,718
Ensembl chr 9:64,862,878...65,006,515
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADAMTS1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADAMTS9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
Tunicamycin results in increased expression of ADIPOQ mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
Tunicamycin results in increased expression of ADM mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adm2 |
adrenomedullin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ADM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Adora2b |
adenosine A2B receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADORA2B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Adprm |
ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent |
increases expression |
ISO |
Tunicamycin results in increased expression of ADPRM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:51,732,073...51,744,635
Ensembl chr10:51,731,993...51,744,635
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADRM1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of AEN mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Aga |
aspartylglucosaminidase |
increases expression |
ISO |
Tunicamycin results in increased expression of AGA mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:38,504,661...38,516,607
Ensembl chr16:38,504,663...38,516,606
|
|
G |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AGAP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:90,039,720...90,475,196
Ensembl chr 9:90,039,605...90,470,958
|
|
G |
Agk |
acylglycerol kinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AGK mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:69,114,850...69,193,989
Ensembl chr 4:69,114,269...69,193,934
|
|
G |
Agtpbp1 |
ATP/GTP binding carboxypeptidase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AGTPBP1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869
|
|
G |
Ahcyl2 |
adenosylhomocysteinase-like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AHCYL2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:58,381,290...58,531,061
Ensembl chr 4:58,381,218...58,531,060
|
|
G |
Ahi1 |
Abelson helper integration site 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AHI1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
|
|
G |
Ahnak |
AHNAK nucleoprotein |
increases expression |
ISO |
Tunicamycin results in increased expression of AHNAK mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Ahsa1 |
activator of Hsp90 ATPase activity 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AHSA1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of AIF1 protein]] |
CTD |
PMID:37394652 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Ak2 |
adenylate kinase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AK2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AK3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AK4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Ak5 |
adenylate kinase 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of AK5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
|
|
G |
Akap17a |
A-kinase anchoring protein 17A |
increases expression |
ISO |
Tunicamycin results in increased expression of AKAP17A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
|
|
G |
Akap8 |
A-kinase anchoring protein 8 |
increases expression |
ISO |
Tunicamycin results in increased expression of AKAP8 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
|
|
G |
Akna |
AT-hook transcription factor |
increases expression |
ISO |
Tunicamycin results in increased expression of AKNA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AKR1C21 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions increases phosphorylation |
ISO EXP |
Tunicamycin results in decreased phosphorylation of AKT1 protein [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein] Curcumin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein]; MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:22378314 PMID:24680926 PMID:24898257 PMID:25398788 PMID:36640941 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
increases phosphorylation multiple interactions |
ISO |
Tunicamycin results in increased phosphorylation of AKT2 protein Curcumin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT2 protein] |
CTD |
PMID:36640941 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Akt3 |
AKT serine/threonine kinase 3 |
increases phosphorylation multiple interactions |
ISO |
Tunicamycin results in increased phosphorylation of AKT3 protein Curcumin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT3 protein] |
CTD |
PMID:36640941 |
|
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ALDH1A2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ALDH5A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ALDH6A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ALDH7A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of ALDOC mRNA Tunicamycin results in increased expression of ALDOC mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alg5 |
ALG5, dolichyl-phosphate beta-glucosyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of ALG5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:138,936,998...138,951,228
Ensembl chr 2:138,936,993...138,951,216
|
|
G |
Alg9 |
ALG9, alpha-1,2-mannosyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of ALG9 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
|
|
G |
Alkbh3 |
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase |
increases expression |
ISO |
Tunicamycin results in increased expression of ALKBH3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:79,939,515...79,972,820
Ensembl chr 3:79,939,600...79,972,000
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions increases degradation |
ISO EXP |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; Tretinoin inhibits the reaction [Tunicamycin results in increased degradation of ALPL protein]; Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] |
CTD |
PMID:10567916 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amot |
angiomotin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AMOT mRNA |
CTD |
PMID:29453283 |
|
NCBI chr X:108,982,399...109,041,265
Ensembl chr X:108,984,022...109,041,272
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of AMT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
|
|
G |
Anapc11 |
anaphase promoting complex subunit 11 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANAPC11 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:105,875,209...105,886,307
|
|
G |
Anapc15 |
anaphase promoting complex subunit 15 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANAPC15 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:156,238,640...156,266,005
Ensembl chr 1:156,262,841...156,268,145
|
|
G |
Anapc16 |
anaphase promoting complex subunit 16 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANAPC16 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:27,927,334...27,941,644
Ensembl chr20:27,927,334...27,941,984
|
|
G |
Anapc7 |
anaphase promoting complex subunit 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANAPC7 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:34,131,214...34,160,819
Ensembl chr12:34,133,429...34,160,005
|
|
G |
Angptl3 |
angiopoietin-like 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Ank2 |
ankyrin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANK2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANKRD1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd12 |
ankyrin repeat domain 12 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANKRD12 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:105,583,273...105,687,957
Ensembl chr 9:105,584,065...105,687,911
|
|
G |
Ankrd39 |
ankyrin repeat domain 39 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANKRD39 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:38,780,291...38,790,177
Ensembl chr 9:38,781,785...38,790,201
|
|
G |
Ano10 |
anoctamin 10 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANO10 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:121,841,664...121,960,739
Ensembl chr 8:121,841,665...121,962,670
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANXA1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANXA3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa4 |
annexin A4 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANXA4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Anxa6 |
annexin A6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANXA6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Ap1b1 |
adaptor related protein complex 1 subunit beta 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AP1B1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778
|
|
G |
Ap3d1 |
adaptor related protein complex 3 subunit delta 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP3D1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
|
|
G |
Ap3m2 |
adaptor related protein complex 3 subunit mu 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP3M2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431
|
|
G |
Ap3s2 |
adaptor related protein complex 3 subunit sigma 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP3S2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:133,818,825...133,859,269
Ensembl chr 1:133,818,825...133,859,322
|
|
G |
Ap5s1 |
adaptor related protein complex 5 subunit sigma 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP5S1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 3:118,429,618...118,432,929
Ensembl chr 3:118,429,637...118,432,926
|
|
G |
Apcs |
amyloid P component, serum |
increases expression |
ISO |
Tunicamycin results in increased expression of APCS mRNA |
CTD |
PMID:22414386 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apex2 |
apurinic/apyrimidinic endodeoxyribonuclease 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of APEX2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
|
|
G |
Apob |
apolipoprotein B |
decreases secretion multiple interactions |
ISO |
Tunicamycin results in decreased secretion of APOB protein [ursodoxicoltaurine co-treated with Tunicamycin] results in increased expression of APOB mRNA; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in decreased secretion of APOB protein] |
CTD |
PMID:32535746 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc2 |
apolipoprotein C2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of APOC2 mRNA |
CTD |
PMID:17127020 PMID:22414386 |
|
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of APOC3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions increases secretion |
ISO |
[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA; ATF4 protein affects the reaction [[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form]; Quercetin inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form] |
CTD |
PMID:22115781 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arcn1 |
archain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARCN1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:45,057,617...45,082,224
Ensembl chr 8:45,057,619...45,082,247
|
|
G |
Arf4 |
ADP-ribosylation factor 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARF4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:1,896,692...1,913,267
Ensembl chr16:1,896,546...1,913,261
|
|
G |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARFGAP3 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 7:114,432,873...114,479,206
Ensembl chr 7:114,432,873...114,479,208
|
|
G |
Arg2 |
arginase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARG2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap45 |
Rho GTPase activating protein 45 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARHGAP45 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arhgef2 |
Rho/Rac guanine nucleotide exchange factor 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARHGEF2 mRNA; Tunicamycin results in increased expression of ARHGEF2 protein |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
|
|
G |
Arid3b |
AT-rich interaction domain 3B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARID3B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARID5B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
|
|
G |
Arih2 |
ariadne RBR E3 ubiquitin protein ligase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARIH2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852
|
|
G |
Arl1 |
ADP-ribosylation factor like GTPase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARL1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARMCX1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
|
|
G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARMCX3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
|
|
G |
Arrb1 |
arrestin, beta 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARRB1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Arrdc4 |
arrestin domain containing 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARRDC4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
|
|
G |
Asb3 |
ankyrin repeat and SOCS box-containing 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASB3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:104,659,406...104,788,032
Ensembl chr14:104,611,010...104,788,028
|
|
G |
Ascc2 |
activating signal cointegrator 1 complex subunit 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASCC2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:79,503,449...79,547,801
Ensembl chr14:79,503,517...79,545,494
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ASF1B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASGR1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of ASNS mRNA Luteolin inhibits the reaction [Tunicamycin results in increased expression of ASNS mRNA] |
CTD |
PMID:22378314 PMID:29453283 PMID:32407927 PMID:33545341 PMID:36586010 PMID:38498338 More...
|
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASS1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atad3a |
ATPase family, AAA domain containing 3A |
increases expression |
ISO |
Tunicamycin results in increased expression of ATAD3A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:166,350,302...166,370,492
Ensembl chr 5:166,350,304...166,370,482
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATF3 mRNA |
CTD |
PMID:17127020 PMID:22935518 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 More...
|
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases phosphorylation increases expression multiple interactions |
ISO EXP |
Tunicamycin results in increased phosphorylation of ATF4 protein Tunicamycin results in increased expression of ATF4 mRNA; Tunicamycin results in increased expression of ATF4 protein 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; ATF4 protein affects the reaction [[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA]; Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; leonurine inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; ATF4 protein affects the reaction [Tunicamycin results in increased expression of SESN2 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of ATF4 protein] |
CTD |
PMID:14604972 PMID:22001960 PMID:22115781 PMID:22378314 PMID:22959463 PMID:22959925 PMID:23741617 PMID:24291486 PMID:24312631 PMID:24648495 PMID:24892553 PMID:27358234 PMID:28688763 PMID:28743512 PMID:28844859 PMID:29453283 PMID:29793971 PMID:30592132 PMID:32357311 PMID:32578922 PMID:32740777 PMID:36030031 PMID:36473502 PMID:36586010 PMID:36640941 PMID:38670420 More...
|
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATF5 mRNA |
CTD |
PMID:22378314 PMID:28942281 PMID:29453283 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions increases expression decreases cleavage increases cleavage increases expression |
EXP ISO |
ibutilide inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein] Tunicamycin results in decreased cleavage of ATF6 protein Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein; Tunicamycin results in increased expression of ATF6 protein modified form 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF6 mRNA]; 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein] Tunicamycin results in increased cleavage of ATF6 protein Luteolin inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein modified form] tunicamycin increases expression of Atf6 mRNA in liver naltrexone inhibits the reaction [tunicamycin increases expression of Atf6 mRNA in liver] |
CTD RGD |
PMID:18477628 PMID:22001960 PMID:22378314 PMID:22959463 PMID:22959925 PMID:24648495 PMID:25160872 PMID:26551149 PMID:28399139 PMID:29723631 PMID:29894845 PMID:30592132 PMID:32407927 PMID:32740777 PMID:36030031 PMID:27813192 PMID:27813192 More...
|
RGD:401842386, RGD:401842386 |
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg13 |
autophagy related 13 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATG13 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG4B protein] |
CTD |
PMID:36640941 |
|
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions increases response to substance increases expression |
ISO EXP |
[ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DDIT3 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DNAJB9 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of EIF2AK3 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of HSPA5 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of PPP1R15A mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of SQSTM1 protein; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of XBP1 mRNA; ATG5 protein mutant form inhibits the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein] Tunicamycin results in increased expression of ATG5 mRNA Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] Tunicamycin results in increased expression of ATG5 mRNA; Tunicamycin results in increased expression of ATG5 protein |
CTD |
PMID:29793971 PMID:36640941 PMID:37654027 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atl2 |
atlastin GTPase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATL2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
|
|
G |
Atp11b |
ATPase phospholipid transporting 11B (putative) |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP11B mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:118,585,348...118,691,076
Ensembl chr 2:118,585,342...118,690,232
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP2A2 mRNA |
CTD |
PMID:17127020 PMID:29453283 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atp5mc3 |
ATP synthase membrane subunit c locus 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5MC3 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
|
|
G |
Atp5mf |
ATP synthase membrane subunit f |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5MF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5PD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atp6v0a1 |
ATPase H+ transporting V0 subunit a1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP6V0A1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:85,935,802...85,989,901
Ensembl chr10:85,935,854...85,989,895
|
|
G |
Atp6v0a2 |
ATPase H+ transporting V0 subunit a2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP6V0A2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:31,947,220...31,979,875
Ensembl chr12:31,822,733...32,007,069
|
|
G |
Atp6v0e1 |
ATPase H+ transporting V0 subunit e1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP6V0E1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP6V1D mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Atp6v1g1 |
ATPase H+ transporting V1 subunit G1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP6V1G1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:76,961,462...76,967,642
Ensembl chr 5:76,961,499...76,969,463
|
|
G |
Atp6v1g2 |
ATPase H+ transporting V1 subunit G2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP6V1G2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr20:3,587,681...3,591,309
Ensembl chr20:3,587,686...3,590,481
|
|
G |
Atp7b |
ATPase copper transporting beta |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP7B mRNA |
CTD |
PMID:17127020 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Atp8a1 |
ATPase phospholipid transporting 8A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP8A1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
|
|
G |
Auh |
AU RNA binding methylglutaconyl-CoA hydratase |
increases expression |
ISO |
Tunicamycin results in increased expression of AUH mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:12,329,522...12,424,882
Ensembl chr17:12,329,524...12,424,896
|
|
G |
Aurka |
aurora kinase A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AURKA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AURKB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
B3galt1 |
Beta-1,3-galactosyltransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of B3GALT1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:52,253,413...52,826,508
Ensembl chr 3:52,253,618...52,825,313
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of B4GALT1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of B4GALT5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
|
|
G |
B9d1 |
B9 domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of B9D1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
ISO |
Tunicamycin results in increased expression of BAD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases activity |
ISO |
Tunicamycin results in increased activity of BAK1 protein |
CTD |
PMID:17553788 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BAMBI mRNA |
CTD |
PMID:29453283 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Banf1 |
BAF nuclear assembly factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BANF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BASP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases activity |
ISO |
Tunicamycin results in increased activity of BAX protein |
CTD |
PMID:17553788 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of BBC3 mRNA |
CTD |
PMID:22378314 PMID:33545341 PMID:38498338 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BCAT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bckdha |
branched chain keto acid dehydrogenase E1 subunit alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of BCKDHA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
|
|
G |
Bckdhb |
branched chain keto acid dehydrogenase E1 subunit beta |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BCKDHB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BCKDK mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Bcl11a |
BCL11 transcription factor A |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL11A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of BCL2 mRNA Tunicamycin results in increased expression of BCL2 mRNA |
CTD |
PMID:17127020 PMID:33545341 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of BCL2L11 protein Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased expression of BCL2L11 protein] |
CTD |
PMID:36509116 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL2L2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bcs1l |
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone |
increases expression |
ISO |
Tunicamycin results in increased expression of BCS1L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:76,164,925...76,168,940
Ensembl chr 9:76,164,932...76,168,938
|
|
G |
Becn1 |
beclin 1 |
increases expression |
EXP |
Tunicamycin results in increased expression of BECN1 mRNA; Tunicamycin results in increased expression of BECN1 protein |
CTD |
PMID:37654027 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Begain |
brain-enriched guanylate kinase-associated |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BEGAIN mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841
|
|
G |
Bend6 |
BEN domain containing 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of BEND6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:36,081,033...36,135,309
Ensembl chr 9:36,081,484...36,135,228
|
|
G |
Best1 |
bestrophin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BEST1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:206,629,340...206,646,085
Ensembl chr 1:206,629,500...206,646,063
|
|
G |
Bet1 |
Bet1 golgi vesicular membrane trafficking protein |
increases expression |
ISO |
Tunicamycin results in increased expression of BET1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:32,116,232...32,126,592
Ensembl chr 4:32,116,235...32,126,617
|
|
G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
increases expression |
ISO |
Tunicamycin results in increased expression of BET1L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
|
|
G |
Bex1 |
brain expressed X-linked 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BEX2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
|
|
G |
Bex2 |
brain expressed X-linked 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BEX1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BID mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BIRC5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BIRC6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
Bloc1s1 |
biogenesis of lysosomal organelles complex-1, subunit 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BLOC1S1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:1,347,495...1,351,103
Ensembl chr 7:1,340,934...1,351,558
|
|
G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BLOC1S2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
|
|
G |
Blzf1 |
basic leucine zipper nuclear factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BLZF1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:76,641,757...76,656,977
Ensembl chr13:76,641,515...76,656,999
|
|
G |
Bmp1 |
bone morphogenetic protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BMP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BMP2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bmp8a |
bone morphogenetic protein 8a |
increases expression |
ISO |
Tunicamycin results in increased expression of BMP8A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:135,589,839...135,617,785
Ensembl chr 5:135,591,716...135,617,785
|
|
G |
Bnc2 |
basonuclin zinc finger protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BNC2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:98,679,071...99,016,044
Ensembl chr 5:98,687,410...99,079,426
|
|
G |
Bnip1 |
BCL2 interacting protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BNIP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BNIP3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BNIP3L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Bola3 |
bolA family member 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BOLA3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797
|
|
G |
Bphl |
biphenyl hydrolase like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BPHL mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
ISO |
Tunicamycin results in increased expression of BRCA1 protein |
CTD |
PMID:16434996 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
increases expression |
ISO |
Tunicamycin results in increased expression of BRCA2 protein |
CTD |
PMID:16434996 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brd2 |
bromodomain containing 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BRD2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Brinp1 |
BMP/retinoic acid inducible neural specific 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BRINP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
|
|
G |
Brix1 |
biogenesis of ribosomes BRX1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BRIX1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:59,450,614...59,461,495
|
|
G |
Bsg |
basigin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BSG mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
increases expression |
ISO |
Tunicamycin results in increased expression of BSN mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BUB1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BUB1B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Bud31 |
BUD31 homolog |
increases expression |
ISO |
Tunicamycin results in increased expression of BUD31 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:9,462,838...9,470,387
Ensembl chr12:9,462,441...9,470,509
|
|
G |
C10h17orf100 |
similar to human chromosome 17 open reading frame 100 |
increases expression |
ISO |
Tunicamycin results in increased expression of C17ORF100 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
|
|
G |
C10h17orf49 |
similar to human chromosome 17 open reading frame 49 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of C17ORF49 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:54,951,991...54,954,756
Ensembl chr10:54,951,991...54,956,601
|
|
G |
C10h17orf58 |
similar to human chromosome 17 open reading frame 58 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of C17ORF58 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
|
|
G |
C11h3orf52 |
similar to human chromosome 3 open reading frame 52 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of C3ORF52 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr11:55,166,986...55,192,273
Ensembl chr11:55,166,678...55,192,292
|
|
G |
C1qbp |
complement C1q binding protein |
decreases expression |
ISO |
Tunicamycin results in decreased expression of C1QBP mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C2h1orf162 |
similar to human chromosome 1 open reading frame 162 |
increases expression |
ISO |
Tunicamycin results in increased expression of C1ORF162 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:193,410,730...193,420,824
Ensembl chr 2:193,412,971...193,420,030
|
|
G |
C3h11orf96 |
similar to human chromosome 11 open reading frame 96 |
increases expression |
ISO |
Tunicamycin results in increased expression of C11ORF96 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:79,920,125...79,921,368
Ensembl chr 3:79,920,129...79,921,523
|
|
G |
C5h1orf122 |
similar to human chromosome 1 open reading frame 122 |
increases expression |
ISO |
Tunicamycin results in increased expression of C1ORF122 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:137,109,093...137,110,130
Ensembl chr 5:137,108,633...137,110,929
|
|
G |
C9h6orf141 |
similar to human chromosome 6 open reading frame 141 |
increases expression |
ISO |
Tunicamycin results in increased expression of C6ORF141 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:20,024,916...20,029,094
Ensembl chr 9:20,024,916...20,029,094
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
increases expression |
ISO |
Tunicamycin results in increased expression of CACNA1C mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CACNA2D2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CACNB2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Cacng4 |
calcium voltage-gated channel auxiliary subunit gamma 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CACNG4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:92,683,778...92,745,842
Ensembl chr10:92,683,761...92,746,126
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
increases expression |
ISO |
Tunicamycin results in increased expression of CAD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CADM1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calcb |
calcitonin-related polypeptide, beta |
increases expression |
ISO |
Tunicamycin results in increased expression of CALCB mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:168,965,383...168,970,259
Ensembl chr 1:168,966,465...168,970,125
|
|
G |
Calm1 |
calmodulin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CALM1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Calm2 |
calmodulin 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CALM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
|
|
G |
Calm3 |
calmodulin 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CALM3 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Calr |
calreticulin |
increases expression |
EXP ISO |
Tunicamycin results in increased expression of CALR protein Tunicamycin results in increased expression of CALR mRNA Tunicamycin results in increased expression of CALR mRNA; Tunicamycin results in increased expression of CALR protein |
CTD |
PMID:15049342 PMID:22001960 PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 More...
|
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Calu |
calumenin |
increases expression multiple interactions decreases expression |
ISO EXP |
Tunicamycin results in increased expression of CALU mRNA ibutilide inhibits the reaction [Tunicamycin results in decreased expression of CALU mRNA]; ibutilide inhibits the reaction [Tunicamycin results in decreased expression of CALU protein] Tunicamycin results in decreased expression of CALU mRNA; Tunicamycin results in decreased expression of CALU protein |
CTD |
PMID:22378314 PMID:28399139 |
|
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
|
|
G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CAMK1D mRNA |
CTD |
PMID:17127020 |
|
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
|
|
G |
Camk1g |
calcium/calmodulin-dependent protein kinase IG |
increases expression |
ISO |
Tunicamycin results in increased expression of CAMK1G mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CAMK4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Canx |
calnexin |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of CANX mRNA; Tunicamycin results in increased expression of CANX protein ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of CANX protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of CANX protein] |
CTD |
PMID:22378314 PMID:27588471 PMID:29453283 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Car10 |
carbonic anhydrase 10 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CA10 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CA2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car5b |
carbonic anhydrase 5B |
increases expression |
ISO |
Tunicamycin results in increased expression of CA5B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:30,474,697...30,534,797
Ensembl chr X:30,474,784...30,533,837
|
|
G |
Card9 |
caspase recruitment domain family, member 9 |
increases expression |
ISO |
Tunicamycin results in increased expression of CARD9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
|
|
G |
Carhsp1 |
calcium regulated heat stable protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CARHSP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CARS1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Casp1 |
caspase 1 |
increases activity |
EXP |
Tunicamycin results in increased activity of CASP1 protein |
CTD |
PMID:37654027 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
increases cleavage multiple interactions increases activity |
ISO EXP |
Tunicamycin results in increased cleavage of CASP12 protein Nicotine inhibits the reaction [Tunicamycin results in increased activity of CASP12 protein] resveratrol inhibits the reaction [Tunicamycin results in increased activity of CASP12 protein] |
CTD |
PMID:17003819 PMID:18477628 PMID:24224909 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp2 |
caspase 2 |
multiple interactions increases activity decreases expression |
ISO |
Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP2 protein] Tunicamycin results in decreased expression of CASP2 mRNA |
CTD |
PMID:16388830 PMID:22378314 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases activity increases expression |
ISO EXP |
Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased cleavage of CASP3 protein]; Bortezomib promotes the reaction [Tunicamycin results in increased activity of CASP3 protein]; Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased cleavage of CASP3 protein] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form]; [spautin-1 results in decreased susceptibility to Tunicamycin] which results in decreased expression of CASP3 protein modified form; Luteolin inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form]; TRP53 protein affects the reaction [HR protein affects the reaction [Tunicamycin results in increased activity of CASP3 protein]]; Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased cleavage of CASP3 protein]] 1-Deoxynojirimycin inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; HR protein inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein] |
CTD |
PMID:12871656 PMID:14747384 PMID:16357177 PMID:16388830 PMID:17553788 PMID:19028522 PMID:19735704 PMID:20886113 PMID:24680926 PMID:28399139 PMID:29793971 PMID:31330229 PMID:32407927 PMID:36509116 PMID:37394652 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
decreases expression increases cleavage |
ISO |
Tunicamycin results in decreased expression of CASP4 mRNA Tunicamycin results in increased cleavage of CASP4 protein |
CTD |
PMID:17127020 PMID:26551149 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CASP6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
increases activity increases expression |
ISO |
Tunicamycin results in increased activity of CASP7 protein Tunicamycin results in increased expression of CASP7 protein modified form |
CTD |
PMID:19139269 PMID:31330229 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity increases cleavage increases expression |
ISO |
Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP9 protein] Tunicamycin results in increased cleavage of CASP9 protein Tunicamycin results in increased expression of CASP9 mRNA Tunicamycin results in increased expression of CASP9 protein modified form |
CTD |
PMID:14747384 PMID:16388830 PMID:17553788 PMID:22378314 PMID:31330229 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cblb |
Cbl proto-oncogene B |
increases expression |
ISO |
Tunicamycin results in increased expression of CBLB mRNA |
CTD |
PMID:38498338 |
|
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Cbln2 |
cerebellin 2 precursor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CBLN2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:79,940,412...79,948,766
Ensembl chr18:79,942,590...79,947,855
|
|
G |
Cbs |
cystathionine beta synthase |
increases expression |
ISO |
Tunicamycin results in increased expression of CBS mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Cbx4 |
chromobox 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CBX4 mRNA |
CTD |
PMID:22378314 PMID:33545341 PMID:38498338 |
|
NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
|
|
G |
Cbx6 |
chromobox 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CBX6 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 7:111,372,979...111,383,026
Ensembl chr 7:111,372,980...111,383,091
|
|
G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCAR1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
increases expression |
ISO |
Tunicamycin results in increased expression of CFAP263 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc167 |
coiled-coil domain containing 167 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCDC167 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:7,763,927...7,782,090
Ensembl chr20:7,751,782...7,781,613
|
|
G |
Ccdc171 |
coiled-coil domain containing 171 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCDC171 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:97,919,965...98,403,853
Ensembl chr 5:97,920,002...98,282,833
|
|
G |
Ccdc24 |
coiled-coil domain containing 24 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of CCDC24 mRNA Tunicamycin results in decreased expression of CCDC24 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:131,398,766...131,412,395
Ensembl chr 5:131,408,143...131,412,029
|
|
G |
Ccdc28a |
coiled-coil domain containing 28A |
increases expression |
ISO |
Tunicamycin results in increased expression of CCDC28A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression increases expression |
ISO |
Tunicamycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] Tunicamycin results in decreased expression of CCL2 mRNA Tunicamycin results in increased expression of CCL2 mRNA |
CTD |
PMID:18799549 PMID:22378314 PMID:38498338 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCL20 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCL3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCL4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccn1 |
cellular communication network factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYR61 mRNA |
CTD |
PMID:36586010 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCN3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNA1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNA2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNB1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb1ip1 |
cyclin B1 interacting protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCNB1IP1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:24,014,905...24,031,357
Ensembl chr15:24,014,908...24,028,475
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCND1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccnt2 |
cyclin T2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCNT2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019
|
|
G |
Ccnyl1 |
cyclin Y-like 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNYL1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:66,071,721...66,121,742
Ensembl chr 9:66,071,543...66,107,999
|
|
G |
Ccpg1 |
cell cycle progression 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCPG1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
|
|
G |
Cct6a |
chaperonin containing TCP1 subunit 6A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCT6A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CD24 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd248 |
CD248 molecule |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CD248 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,373,676...202,376,240
Ensembl chr 1:202,373,676...202,376,240
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
increases expression |
ISO |
Tunicamycin results in increased expression of CD55 mRNA |
CTD |
PMID:17127020 PMID:29453283 PMID:33545341 PMID:38498338 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd69 |
Cd69 molecule |
increases expression |
ISO |
Tunicamycin results in increased expression of CD69 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cdc27 |
cell division cycle 27 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDC27 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
|
|
G |
Cdc45 |
cell division cycle 45 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDC45 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc6 |
cell division cycle 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDC6 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdc7 |
cell division cycle 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDC7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdca2 |
cell division cycle associated 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of CDCA3 mRNA Tunicamycin results in decreased expression of CDCA3 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdca7 |
cell division cycle associated 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA7 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
|
|
G |
Cdca7l |
cell division cycle associated 7 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA7L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:138,793,953...138,839,889
Ensembl chr 6:138,794,228...138,839,888
|
|
G |
Cdca8 |
cell division cycle associated 8 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA8 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh10 |
cadherin 10 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH10 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:68,628,623...68,850,995
Ensembl chr 2:68,628,780...68,850,995
|
|
G |
Cdh13 |
cadherin 13 |
multiple interactions |
ISO |
Tunicamycin promotes the reaction [HSPA5 protein binds to CDH13 protein] |
CTD |
PMID:23544152 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdh15 |
cadherin 15 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH15 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:50,903,757...50,927,151
Ensembl chr19:50,903,638...50,927,105
|
|
G |
Cdh2 |
cadherin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh22 |
cadherin 22 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDH22 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDK2AP2 mRNA |
CTD |
PMID:17127020 PMID:22378314 PMID:29453283 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK5R1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDK5RAP3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:81,894,393...81,903,581
Ensembl chr10:81,894,393...81,903,590
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDK7 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
|
|
G |
Cdkl3 |
cyclin-dependent kinase-like 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDKL3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:36,263,212...36,349,268
Ensembl chr10:36,266,977...36,349,268
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDKN1C mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDO1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cdr2 |
cerebellar degeneration-related protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDR2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:175,502,837...175,527,746
Ensembl chr 1:175,502,838...175,537,472
|
|
G |
Cdrt4 |
CMT1A duplicated region transcript 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDRT4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:47,625,470...47,657,493
Ensembl chr10:47,625,470...47,657,493
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of CEBPB mRNA CEBPB protein inhibits the reaction [Tunicamycin results in decreased expression of PPARGC1A protein] |
CTD |
PMID:22378314 PMID:28482072 PMID:29453283 PMID:33545341 PMID:36586010 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
ISO |
Tunicamycin results in increased expression of CEBPG mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Celf1 |
CUGBP, Elav-like family member 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CELF1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:76,924,591...76,999,429
Ensembl chr 3:76,924,613...76,999,426
|
|
G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CELSR3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CENPA mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CENPF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenpu |
centromere protein U |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CENPU mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
|
|
G |
Cep44 |
centrosomal protein 44 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CEP44 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:33,711,548...33,733,226
Ensembl chr16:33,711,559...33,733,225
|
|
G |
Cep55 |
centrosomal protein 55 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CEP55 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Cep68 |
centrosomal protein 68 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CEP68 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr14:94,447,973...94,470,533
Ensembl chr14:94,449,055...94,470,517
|
|
G |
Cep95 |
centrosomal protein 95 |
increases expression |
ISO |
Tunicamycin results in increased expression of CEP95 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
ISO |
Tunicamycin results in increased expression of CFAP300 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
|
|
G |
Cfap61 |
cilia and flagella associated protein 61 |
increases expression |
ISO |
Tunicamycin results in increased expression of CFAP61 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:133,354,400...133,633,310
Ensembl chr 3:133,354,197...133,633,320
|
|
G |
Cfl1 |
cofilin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CFL1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
Tunicamycin results in increased expression of CFLAR mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CGREF1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CHAC1 mRNA |
CTD |
PMID:29453283 PMID:33545341 PMID:36586010 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHD1L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
|
|
G |
Chd7 |
chromodomain helicase DNA binding protein 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHD7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:21,812,007...21,995,358
Ensembl chr 5:21,812,070...21,995,358
|
|
G |
Chga |
chromogranin A |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of CHGA mRNA Tunicamycin results in increased expression of CHGA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
|
|
G |
Chgb |
chromogranin B |
increases expression |
ISO |
Tunicamycin results in increased expression of CHGB mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
|
|
G |
Chpf |
chondroitin polymerizing factor |
increases expression |
ISO |
Tunicamycin results in increased expression of CHPF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CHPT1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of CHRNA4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHRNA5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHRNB4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CHST2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
increases expression |
ISO |
Tunicamycin results in increased expression of CIDEC mRNA |
CTD |
PMID:22414386 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cilk1 |
ciliogenesis associated kinase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CILK1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
|
|
G |
Cirbp |
cold inducible RNA binding protein |
increases expression |
ISO |
Tunicamycin results in increased expression of CIRBP mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CISD2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CITED1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
|
|
G |
Ckb |
creatine kinase B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CKB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ckm |
creatine kinase, M-type |
increases expression |
ISO |
Tunicamycin results in increased expression of CKM mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Ckmt2 |
creatine kinase, mitochondrial 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CKMT2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:23,079,918...23,110,518
Ensembl chr 2:23,079,918...23,110,430
|
|
G |
Clcc1 |
chloride channel CLIC-like 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLCC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:196,296,350...196,326,914
Ensembl chr 2:196,296,393...196,326,913
|
|
G |
Cldn3 |
claudin 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLDN3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn4 |
claudin 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLDN4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldn6 |
claudin 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLDN6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:12,710,302...12,713,987
Ensembl chr10:12,709,960...12,715,973
|
|
G |
Cldn7 |
claudin 7 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLDN7 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
|
|
G |
Clec11a |
C-type lectin domain containing 11A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CLEC11A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:94,800,456...94,809,002
Ensembl chr 1:94,801,496...94,804,633
|
|
G |
Clic5 |
chloride intracellular channel 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLIC5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:16,710,980...16,813,502
Ensembl chr 9:16,710,980...16,813,427
|
|
G |
Cln3 |
CLN3 lysosomal/endosomal transmembrane protein, battenin |
increases expression |
ISO |
Tunicamycin results in increased expression of CLN3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
|
|
G |
Clstn1 |
calsyntenin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CLSTN1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:160,031,235...160,094,585
Ensembl chr 5:160,031,308...160,094,583
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CMPK2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cmss1 |
cms1 ribosomal small subunit homolog |
increases expression |
ISO |
Tunicamycin results in increased expression of CMSS1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr11:42,934,390...43,232,624
Ensembl chr11:42,934,440...43,232,624
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CMTM6 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:114,422,934...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cmtm7 |
CKLF-like MARVEL transmembrane domain containing 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CMTM7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:114,448,037...114,474,958
Ensembl chr 8:114,448,042...114,474,621
|
|
G |
Cnn3 |
calponin 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CNN3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
|
|
G |
Cog3 |
component of oligomeric golgi complex 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of COG3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
|
|
G |
Cog6 |
component of oligomeric golgi complex 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of COG6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:137,062,127...137,099,176
Ensembl chr 2:137,061,346...137,099,190
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COL4A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
increases expression |
ISO |
Tunicamycin results in increased expression of COL4A5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr X:105,118,762...105,322,699
Ensembl chr X:105,118,820...105,322,692
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COL5A1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Colgalt1 |
collagen beta(1-O)galactosyltransferase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COLGALT1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:18,319,796...18,332,106
Ensembl chr16:18,319,795...18,332,106
|
|
G |
Colgalt2 |
collagen beta(1-O)galactosyltransferase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of COLGALT2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr13:64,523,641...64,628,295
Ensembl chr13:64,523,658...64,627,549
|
|
G |
Commd5 |
COMM domain containing 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of COMMD5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Comtd1 |
catechol-O-methyltransferase domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of COMTD1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895
|
|
G |
Cop1 |
COP1, E3 ubiquitin ligase |
increases expression |
ISO |
Tunicamycin results in increased expression of COP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:71,467,164...71,561,826
Ensembl chr13:71,429,961...71,538,890
|
|
G |
Copa |
COPI coat complex subunit alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of COPA mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
|
|
G |
Copb1 |
COPI coat complex subunit beta 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of COPB1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:168,404,334...168,438,589
Ensembl chr 1:168,404,335...168,438,416
|
|
G |
Copb2 |
COPI coat complex subunit beta 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of COPB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:99,161,324...99,183,452
Ensembl chr 8:99,161,350...99,185,197
|
|
G |
Cope |
COPI coat complex subunit epsilon |
increases expression |
ISO |
Tunicamycin results in increased expression of COPE mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of COPG1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Coq10b |
coenzyme Q10B |
increases expression |
ISO |
Tunicamycin results in increased expression of COQ10B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
|
|
G |
Coq3 |
coenzyme Q3 methyltransferase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COQ3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:35,429,567...35,460,613
Ensembl chr 5:35,429,574...35,460,607
|
|
G |
Coq7 |
coenzyme Q7, hydroxylase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COQ7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
|
|
G |
Coq8a |
coenzyme Q8A |
increases expression |
ISO |
Tunicamycin results in increased expression of COQ8A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
|
|
G |
Coro1a |
coronin 1A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CORO1A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
increases expression |
ISO |
Tunicamycin results in increased expression of COX11 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox16 |
cytochrome c oxidase assembly factor COX16 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX16 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 6:101,162,231...101,181,277
Ensembl chr 6:101,019,680...101,181,246
|
|
G |
Cox19 |
cytochrome c oxidase assembly factor COX19 |
increases expression |
ISO |
Tunicamycin results in increased expression of COX19 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:15,303,535...15,313,014
Ensembl chr12:15,303,551...15,313,014
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX4I1 protein |
CTD |
PMID:36473502 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cox6b1 |
cytochrome c oxidase subunit 6B1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX6B1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001
|
|
G |
Cox6c |
cytochrome c oxidase subunit 6C |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX6C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:67,129,265...67,142,001
Ensembl chr 7:67,111,024...67,141,963
|
|
G |
Cox7b |
cytochrome c oxidase subunit 7B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX7B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:71,083,486...71,089,733
Ensembl chr X:71,083,456...71,089,732
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX7C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX8A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:204,402,118...204,404,439
|
|
G |
Cpa4 |
carboxypeptidase A4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CPA4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
|
|
G |
Cpd |
carboxypeptidase D |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CPD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
|
|
G |
Cpe |
carboxypeptidase E |
increases expression |
ISO |
Tunicamycin results in increased expression of CPE mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CPEB3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
ISO |
Tunicamycin results in increased expression of CPT1C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRABP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRABP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRADD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of CRAT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CREB3L2 mRNA |
CTD |
PMID:17127020 PMID:22378314 PMID:29453283 |
|
NCBI chr 4:65,907,570...66,112,078
Ensembl chr 4:65,907,655...66,023,763
|
|
G |
Creb3l4 |
cAMP responsive element binding protein 3-like 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CREB3L4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
|
|
G |
Crebrf |
CREB3 regulatory factor |
increases expression |
ISO |
Tunicamycin results in increased expression of CREBRF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRELD1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRELD2 mRNA; Tunicamycin results in increased expression of CRELD2 protein |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crtac1 |
cartilage acidic protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRTAC1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRY1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Crybb2 |
crystallin, beta B2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRYBB2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:43,569,747...43,579,671
Ensembl chr12:43,569,747...43,579,671
|
|
G |
Cse1l |
chromosome segregation 1 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CSE1L mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:155,641,104...155,678,866
Ensembl chr 3:155,641,166...155,678,865
|
|
G |
Csnk1d |
casein kinase 1, delta |
increases expression |
ISO |
Tunicamycin results in increased expression of CSNK1D mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
|
|
G |
Csnk1g1 |
casein kinase 1, gamma 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSNK1G1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:66,439,760...66,577,247
Ensembl chr 8:66,439,864...66,572,826
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSNK2A2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSRNP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSRP1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CSRP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Ctcf |
CCCTC-binding factor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTCF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
|
|
G |
Cth |
cystathionine gamma-lyase |
increases expression |
ISO |
Tunicamycin results in increased expression of CTH mRNA; Tunicamycin results in increased expression of CTH protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnna1 |
catenin alpha 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTNNA1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTNNBL1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:146,387,940...146,548,987
Ensembl chr 3:146,387,889...146,548,987
|
|
G |
Ctnnd2 |
catenin delta 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTNND2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764
|
|
G |
Ctps1 |
CTP synthase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTPS1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
Tunicamycin results in increased expression of CTSD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cuedc2 |
CUE domain containing 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CUEDC2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:245,192,057...245,200,594
Ensembl chr 1:245,192,063...245,200,339
|
|
G |
Cul4a |
cullin 4A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CUL4A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CXCL1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CXCL2 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CXCL1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyb561d1 |
cytochrome b561 family, member D1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB561D1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:195,834,884...195,837,524
Ensembl chr 2:195,834,740...195,838,243
|
|
G |
Cyb5a |
cytochrome b5 type A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB5A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyb5b |
cytochrome b5 type B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB5B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cycs |
cytochrome c, somatic |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of CYCS mRNA Tunicamycin results in increased expression of CYCS mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cygb |
cytoglobin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYGB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp2g1 |
cytochrome P450, family 2, subfamily g, polypeptide 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYP2G1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:82,145,635...82,156,862
Ensembl chr 1:82,145,073...82,156,828
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYP39A1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dach1 |
dachshund family transcription factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DACH1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922
|
|
G |
Dap |
death-associated protein |
increases expression |
ISO |
Tunicamycin results in increased expression of DAP mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dbi |
diazepam binding inhibitor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DBI mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dbnl |
drebrin-like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DBNL mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr14:80,666,115...80,681,155
Ensembl chr14:80,666,124...80,681,155
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DBT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
|
|
G |
Dctpp1 |
dCTP pyrophosphatase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DCTPP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:181,877,440...181,880,833
Ensembl chr 1:181,877,437...181,880,839
|
|
G |
Dcx |
doublecortin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DCX mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DDC mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases activity increases expression |
ISO EXP |
2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Bortezomib inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; leonurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; SESN2 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; SESN2 protein promotes the reaction [Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DDIT3 mRNA; [Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Amiloride inhibits the reaction [Tunicamycin results in increased expression of DDIT3]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; Bortezomib inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Tretinoin promotes the reaction [Tunicamycin results in increased expression of DDIT3 mRNA] Tunicamycin results in increased activity of DDIT3 protein 1-Deoxynojirimycin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Guanabenz inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; GW 506033X inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; ibutilide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]; TGFB1 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] Tunicamycin results in increased expression of DDIT3 mRNA; Tunicamycin results in increased expression of DDIT3 protein Tunicamycin results in increased expression of DDIT3; Tunicamycin results in increased expression of DDIT3 mRNA; Tunicamycin results in increased expression of DDIT3 protein |
CTD |
PMID:10542372 PMID:14604972 PMID:16330322 PMID:16357177 PMID:17003819 PMID:17127020 PMID:19028522 PMID:19139269 PMID:19428936 PMID:19735704 PMID:20015086 PMID:20196124 PMID:20477944 PMID:20593179 PMID:20626587 PMID:21321189 PMID:22001960 PMID:22215663 PMID:22378314 PMID:22414386 PMID:22509299 PMID:22935518 PMID:22959463 PMID:22959925 PMID:23123503 PMID:23684743 PMID:23741617 PMID:24210820 PMID:24370435 PMID:24648495 PMID:24680926 PMID:24892553 PMID:25160872 PMID:25324550 PMID:27358234 PMID:28399139 PMID:28482072 PMID:28688763 PMID:28698385 PMID:28844859 PMID:28942281 PMID:29027487 PMID:29289645 PMID:29380555 PMID:29453283 PMID:29723631 PMID:29793971 PMID:30253173 PMID:32407927 PMID:32535746 PMID:32574669 PMID:32578922 PMID:32740777 PMID:33127435 PMID:33545341 PMID:34626751 PMID:36030031 PMID:36586010 PMID:37654027 PMID:38498338 PMID:38670420 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DDIT4 mRNA |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of DDOST mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
|
|
G |
Ddx23 |
DEAD-box helicase 23 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DDX23 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
|
|
G |
Ddx46 |
DEAD-box helicase 46 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DDX46 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
|
|
G |
Ddx49 |
DEAD-box helicase 49 |
increases expression |
ISO |
Tunicamycin results in increased expression of DDX49 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616
|
|
G |
Ddx60 |
DEXD/H-box helicase 60 |
increases expression |
ISO |
Tunicamycin results in increased expression of DDX60 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DECR1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dedd2 |
death effector domain containing 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DEDD2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714
|
|
G |
Depdc1b |
DEP domain containing 1B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DEPDC1B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
increases expression |
ISO |
Tunicamycin results in increased expression of DEPTOR mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Derl2 |
derlin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DERL2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:55,727,764...55,739,442
Ensembl chr10:55,727,643...55,739,518
|
|
G |
Derl3 |
derlin 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DERL3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DGAT1 mRNA |
CTD |
PMID:22414386 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dgkk |
diacylglycerol kinase kappa |
increases expression |
ISO |
Tunicamycin results in increased expression of DGKK mRNA |
CTD |
PMID:17127020 |
|
NCBI chr X:15,581,991...15,713,814
Ensembl chr X:15,583,572...15,712,987
|
|
G |
Dglucy |
D-glutamate cyclase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DGLUCY mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:120,055,480...120,130,910
Ensembl chr 6:120,055,460...120,130,910
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DHCR24 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DHCR7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs13 |
dehydrogenase/reductase 13 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS13 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:62,920,791...62,925,952
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS7 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dhrs7b |
dehydrogenase/reductase 7B |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS7B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
|
|
G |
Dhx9 |
DExH-box helicase 9 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DHX9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
increases expression |
ISO |
Tunicamycin results in increased expression of DIABLO mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DICER1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dis3 |
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of DIS3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:75,820,040...75,850,450
Ensembl chr15:75,823,436...75,850,642
|
|
G |
Dis3l |
DIS3-like exosome 3'-5' exoribonuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of DIS3L mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:64,803,925...64,840,306
Ensembl chr 8:64,803,927...64,840,165
|
|
G |
Disp2 |
dispatched RND transporter family member 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DISP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DLG4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLK1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLL3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of DLST mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Dlx5 |
distal-less homeobox 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLX5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dmac2l |
distal membrane arm assembly component 2 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DMAC2L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933
|
|
G |
Dmkn |
dermokine |
increases expression |
ISO |
Tunicamycin results in increased expression of DMKN mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:86,013,237...86,031,243
Ensembl chr 1:86,014,188...86,030,006
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DMRT1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DMTF1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJA1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJA3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJB1 mRNA |
CTD |
PMID:20196124 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJB11 mRNA; Tunicamycin results in increased expression of DNAJB11 protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
|
|
G |
Dnajb2 |
DnaJ heat shock protein family (Hsp40) member B2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of DNAJB9 mRNA [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DNAJB9 mRNA Luteolin inhibits the reaction [Tunicamycin results in increased expression of DNAJB9 mRNA] |
CTD |
PMID:22001960 PMID:22378314 PMID:23123503 PMID:29453283 PMID:29793971 PMID:32407927 PMID:33545341 PMID:36586010 PMID:38498338 More...
|
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJC10 mRNA; Tunicamycin results in increased expression of DNAJC10 protein |
CTD |
PMID:29453283 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJC12 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJC15 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dnajc17 |
DnaJ heat shock protein family (Hsp40) member C17 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJC17 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:106,162,197...106,195,771
Ensembl chr 3:106,162,197...106,195,751
|
|
G |
Dnajc25 |
DnaJ heat shock protein family (Hsp40) member C25 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJC25 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:73,825,565...73,847,878
Ensembl chr 5:73,825,565...73,845,433
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJC3 mRNA; Tunicamycin results in increased expression of DNAJC3 protein |
CTD |
PMID:24312631 PMID:29453283 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dnase2 |
deoxyribonuclease 2, lysosomal |
increases expression |
ISO |
Tunicamycin results in increased expression of DNASE2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
|
|
G |
Dnhd1 |
dynein heavy chain domain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNHD1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:159,990,785...160,077,990
Ensembl chr 1:159,990,438...160,074,858
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DPAGT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dpf1 |
double PHD fingers 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
|
|
G |
Dph5 |
diphthamide biosynthesis 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of DPH5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:203,804,620...203,858,196
Ensembl chr 2:203,804,936...203,840,433
|
|
G |
Dpp3 |
dipeptidylpeptidase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPP3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPYD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPYSL3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DPYSL4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Dscam |
DS cell adhesion molecule |
increases expression |
ISO |
Tunicamycin results in increased expression of DSCAM mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:35,921,924...36,507,100
Ensembl chr11:35,926,896...36,507,415
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of DTL mRNA Tunicamycin results in increased expression of DTL mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Dus4l |
dihydrouridine synthase 4-like |
increases expression |
ISO |
Tunicamycin results in increased expression of DUS4L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUSP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
increases expression |
ISO |
Tunicamycin results in increased expression of DUSP16 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
|
|
G |
Dusp23 |
dual specificity phosphatase 23 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUSP23 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:85,097,899...85,100,054
Ensembl chr13:85,097,899...85,100,093
|
|
G |
Dusp26 |
dual specificity phosphatase 26 |
increases expression |
ISO |
Tunicamycin results in increased expression of DUSP26 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr16:61,041,784...61,049,319
Ensembl chr16:61,041,792...61,049,051
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUSP5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of DUSP6 mRNA Tunicamycin results in increased expression of DUSP6 mRNA |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dxo |
decapping exoribonuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of DXO mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:3,993,322...3,995,484
Ensembl chr20:3,993,327...3,995,494
|
|
G |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DYNC1I1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:33,852,927...34,166,149
|
|
G |
Dync2i2 |
dynein 2 intermediate chain 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DYNC2I2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:13,306,039...13,322,121
Ensembl chr 3:13,306,039...13,322,121
|
|
G |
Dynll2 |
dynein light chain LC8-type 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DYNLL2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:72,767,035...72,785,824
Ensembl chr10:72,767,035...72,785,805
|
|
G |
Dyrk4 |
dual specificity tyrosine phosphorylation regulated kinase 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DYRK4 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:159,715,658...159,757,660
Ensembl chr 4:159,715,417...159,757,627
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f5 |
E2F transcription factor 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F8 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ebf1 |
EBF transcription factor 1 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of EBF1 mRNA Tunicamycin results in decreased expression of EBF1 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
|
|
G |
Ecd |
ecdysoneless cell cycle regulator |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ECD mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:3,967,209...3,998,713
Ensembl chr15:3,967,382...3,998,706
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ECH1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EDEM1 mRNA; Tunicamycin results in increased expression of EDEM1 protein |
CTD |
PMID:19735704 PMID:22378314 PMID:22414386 PMID:24312631 PMID:29453283 PMID:36586010 More...
|
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Edem2 |
ER degradation enhancing alpha-mannosidase like protein 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of EDEM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485
|
|
G |
Edil3 |
EGF like repeats and discoidin domains 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of EDIL3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of EEF1A2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EEPD1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efhc1 |
EF-hand domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EFHC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
|
|
G |
Efna1 |
ephrin A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EFNA1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Efnb2 |
ephrin B2 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of EFNB2 mRNA Tunicamycin results in decreased expression of EFNB2 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Efs |
embryonal Fyn-associated substrate |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EFS mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EFTUD2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:87,804,893...87,852,181
Ensembl chr10:87,804,892...87,846,079
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EGLN1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egr1 |
early growth response 1 |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of EGR1 mRNA Tunicamycin results in increased expression of EGR1 mRNA |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif1b |
eukaryotic translation initiation factor 1B |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF1B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:120,203,561...120,206,176
Ensembl chr 8:120,203,451...120,206,176
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation increases expression |
ISO |
Tunicamycin results in increased phosphorylation of EIF2A protein Tunicamycin results in increased expression of EIF2A mRNA |
CTD |
PMID:20015086 PMID:22378314 PMID:22959463 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression multiple interactions increases response to substance increases phosphorylation increases expression |
ISO EXP |
Tunicamycin results in increased expression of EIF2AK3 mRNA; Tunicamycin results in increased expression of EIF2AK3 protein Tunicamycin results in increased expression of EIF2AK3 mRNA; Tunicamycin results in increased expression of EIF2AK3 protein modified form 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of EIF2AK3 mRNA; [Tunicamycin co-treated with HRAS protein] results in increased expression of EIF2AK3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]]; Bortezomib inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; Ketoconazole inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to EIF2AK3 protein]; Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein EIF2AK3 gene mutant form results in increased susceptibility to Tunicamycin 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide promotes the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; leonurine inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; Tunicamycin results in increased expression of and results in increased phosphorylation of EIF2AK3 protein 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; ibutilide inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 protein] tunicamycin increases expression of Eif2ak3 mRNA in liver naltrexone inhibits the reaction [tunicamycin increases expression of Eif2ak3 mRNA in liver] |
CTD RGD |
PMID:16330322 PMID:22001960 PMID:22378314 PMID:22509299 PMID:22959925 PMID:23741617 PMID:24224909 PMID:24648495 PMID:24898257 PMID:26551149 PMID:28399139 PMID:29449374 PMID:29793971 PMID:29894845 PMID:30253173 PMID:30592132 PMID:32740777 PMID:36030031 PMID:37654027 PMID:38670420 PMID:27813192 PMID:27813192 More...
|
RGD:401842386, RGD:401842386 |
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
multiple interactions |
ISO |
Tunicamycin inhibits the reaction [[EIF2AK4 gene mutant form affects the susceptibility to Amino Acids deficiency] which results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:29449374 |
|
NCBI chr 3:105,356,261...105,441,630
Ensembl chr 3:105,356,261...105,441,630
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases phosphorylation increases expression decreases phosphorylation |
ISO EXP |
[Tunicamycin results in increased phosphorylation of EIF2S1 protein] which results in decreased expression of MCL1 protein; Bortezomib inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; leonurine inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; NDRG1 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; PTPN1 protein affects the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] Guanabenz promotes the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 mRNA] Tunicamycin results in increased expression of EIF2S1 protein; Tunicamycin results in increased expression of EIF2S1 protein modified form EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein]; Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein Tunicamycin results in decreased phosphorylation of EIF2S1 protein |
CTD |
PMID:16330322 PMID:16357177 PMID:17553788 PMID:22509299 PMID:23741617 PMID:24210820 PMID:24224909 PMID:24532803 PMID:24648495 PMID:24892553 PMID:25160872 PMID:28359145 PMID:28844859 PMID:29109149 PMID:29289645 PMID:29449374 PMID:30253173 PMID:30385349 PMID:30592132 PMID:32407927 PMID:32578922 PMID:36030031 PMID:38670420 More...
|
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF2S2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF4E mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4e2 |
eukaryotic translation initiation factor 4E family member 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EIF4E2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:87,886,126...87,914,470
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF4EBP1 mRNA; Tunicamycin results in increased expression of EIF4EBP1 protein |
CTD |
PMID:29453283 PMID:36586010 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EIF4EBP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EIF5B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ELF3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emc9 |
ER membrane protein complex subunit 9 |
increases expression |
ISO |
Tunicamycin results in increased expression of EMC9 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
|
|
G |
Eml2 |
EMAP like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of EML2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:78,827,595...78,859,342
Ensembl chr 1:78,828,080...78,859,341
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of EMP3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENC1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Endog |
endonuclease G |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENDOG mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Enkd1 |
enkurin domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ENKD1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:33,592,074...33,596,552
Ensembl chr19:33,592,078...33,596,545
|
|
G |
Eno2 |
enolase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENO2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Enosf1 |
enolase superfamily member 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ENOSF1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:113,275,267...113,314,842
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENPP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EPAS1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epha1 |
Eph receptor A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EPHA1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
|
|
G |
Epha7 |
Eph receptor A7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EPHA7 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
|
|
G |
Ephb2 |
Eph receptor B2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EPHB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EPRS1 mRNA; Tunicamycin results in increased expression of EPRS1 protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Epsti1 |
epithelial stromal interaction 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EPSTI1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ERBB3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbin |
erbb2 interacting protein |
increases expression |
ISO |
Tunicamycin results in increased expression of ERBIN mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ERCC6L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
Tunicamycin results in increased expression of EREG mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
multiple interactions decreases expression |
ISO |
ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of CANX protein]; ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein]; ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in decreased expression of ERGIC3 protein] |
CTD |
PMID:27588471 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERLEC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:104,655,745...104,693,508
Ensembl chr14:104,655,673...104,693,480
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases expression increases phosphorylation increases expression |
ISO EXP |
[Tunicamycin co-treated with HRAS protein] results in increased expression of ERN1 protein; Amiloride inhibits the reaction [Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of ERN1 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to ERN1 protein]; Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein Tunicamycin results in increased expression of ERN1 mRNA; Tunicamycin results in increased expression of ERN1 protein; Tunicamycin results in increased expression of ERN1 protein modified form Guanabenz inhibits the reaction [Tunicamycin results in increased phosphorylation of ERN1 protein]; KIRA6 inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein] ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of and results in increased phosphorylation of ERN1 protein]; Tunicamycin results in increased expression of and results in increased phosphorylation of ERN1 protein tunicamycin increases expression of Ern1 mRNA in liver naltrexone inhibits the reaction [tunicamycin increases expression of Ern1 mRNA in liver] |
CTD RGD |
PMID:17127020 PMID:19139269 PMID:20015086 PMID:21432213 PMID:22001960 PMID:22378314 PMID:24224909 PMID:24892553 PMID:24898257 PMID:25160872 PMID:27588471 PMID:29723631 PMID:29894845 PMID:30253173 PMID:32407927 PMID:32535746 PMID:32740777 PMID:36030031 PMID:27813192 PMID:27813192 More...
|
RGD:401842386, RGD:401842386 |
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of ERO1A mRNA |
CTD |
PMID:12752442 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Ero1b |
endoplasmic reticulum oxidoreductase 1 beta |
increases expression |
ISO |
Tunicamycin results in increased expression of ERO1B mRNA |
CTD |
PMID:12752442 PMID:22378314 PMID:29453283 PMID:38498338 |
|
NCBI chr17:85,861,086...86,003,244
Ensembl chr17:85,929,618...86,003,398
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERP29 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Erp44 |
endoplasmic reticulum protein 44 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERP44 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERRFI1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ESPL1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esrp1 |
epithelial splicing regulatory protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ESRP1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
|
|
G |
Esrrg |
estrogen-related receptor gamma |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ESRRG mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ETS2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Etv4 |
ETS variant transcription factor 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ETV4 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ETV5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Exosc2 |
exosome component 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EXOSC2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:14,962,930...14,973,645
Ensembl chr 3:14,962,917...14,973,575
|
|
G |
Exosc5 |
exosome component 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of EXOSC5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Exosc8 |
exosome component 8 |
increases expression |
ISO |
Tunicamycin results in increased expression of EXOSC8 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of F2R mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FABP3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of FABP4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fads3 |
fatty acid desaturase 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of FADS3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769
|
|
G |
Faf1 |
Fas associated factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of FAF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of FAIM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fam110a |
family with sequence similarity 110, member A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM110A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:140,474,484...140,485,074
Ensembl chr 3:140,474,249...140,485,093
|
|
G |
Fam13b |
family with sequence similarity 13, member B |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM13B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
|
|
G |
Fam167a |
family with sequence similarity 167, member A |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM167A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:37,685,221...37,715,472
Ensembl chr15:37,700,919...37,715,469
|
|
G |
Fam174b |
family with sequence similarity 174, member B |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM174B mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:127,515,393...127,618,591
Ensembl chr 1:127,514,041...127,596,128 Ensembl chr 1:127,514,041...127,596,128
|
|
G |
Fam20b |
FAM20B, glycosaminoglycan xylosylkinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM20B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915
|
|
G |
Fam210b |
family with sequence similarity 210, member B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM210B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
|
|
G |
Fam222b |
family with sequence similarity 222, member B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM222B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
|
|
G |
Fam241b |
family with sequence similarity 241 member B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM241B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
|
|
G |
Fam24b |
family with sequence similarity 24 member B |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM24B mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:186,112,544...186,115,957
Ensembl chr 1:186,112,551...186,115,899
|
|
G |
Fam3c |
FAM3 metabolism regulating signaling molecule C |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM3C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM83D mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM89A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Tunicamycin results in increased expression of FAS mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
increases expression decreases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of FASN mRNA Tunicamycin results in decreased expression of FASN mRNA 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA] |
CTD |
PMID:22378314 PMID:22414386 PMID:32407927 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fastkd5 |
FAST kinase domains 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FASTKD5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:117,830,219...117,847,707
Ensembl chr 3:117,830,083...117,847,820
|
|
G |
Fbln1 |
fibulin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FBLN1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FBP1 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbxo16 |
F-box protein 16 |
increases expression |
ISO |
Tunicamycin results in increased expression of FBXO16 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:39,492,268...39,541,493
Ensembl chr15:39,492,377...39,541,480
|
|
G |
Fbxo17 |
F-box protein 17 |
increases expression |
ISO |
Tunicamycin results in increased expression of FBXO17 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:84,002,276...84,024,455
Ensembl chr 1:84,002,267...84,024,453
|
|
G |
Fbxo32 |
F-box protein 32 |
increases expression |
ISO |
Tunicamycin results in increased expression of FBXO32 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fbxw11 |
F-box and WD repeat domain containing 11 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FBXW11 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:17,232,735...17,330,574
Ensembl chr10:17,227,181...17,330,571
|
|
G |
Fcmr |
Fc mu receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FCMR mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FDFT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdxr |
ferredoxin reductase |
increases expression |
ISO |
Tunicamycin results in increased expression of FDXR mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FEN1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FEZ2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions increases expression |
ISO |
FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]]; FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; Tunicamycin inhibits the reaction [FGF21 protein inhibits the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]] FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] Tunicamycin results in increased expression of FGF21 mRNA; Tunicamycin results in increased expression of FGF21 protein |
CTD |
PMID:23123503 PMID:29289645 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
increases expression |
ISO |
Tunicamycin results in increased expression of FGF9 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
increases expression |
ISO |
Tunicamycin results in increased expression of FGGY mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
increases expression |
ISO |
Tunicamycin results in increased expression of FHIT mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fibin |
fin bud initiation factor homolog |
increases expression |
ISO |
Tunicamycin results in increased expression of FIBIN mRNA |
CTD |
PMID:33545341 PMID:38498338 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Fibp |
FGF1 intracellular binding protein |
increases expression |
ISO |
Tunicamycin results in increased expression of FIBP mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
|
|
G |
Ficd |
FIC domain protein adenylyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of FICD mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr12:42,889,195...42,894,090
Ensembl chr12:42,889,194...42,894,070
|
|
G |
Fjx1 |
four-jointed box kinase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FJX1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
increases expression |
ISO |
Tunicamycin results in increased expression of FKBP11 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FLT1 mRNA |
CTD |
PMID:24370435 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FMO1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
increases expression |
ISO |
Tunicamycin results in increased expression of FNDC3B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of FOS mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of FOSB mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxa1 |
forkhead box A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXA1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxd2 |
forkhead box D2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXD2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:128,427,986...128,430,709
Ensembl chr 5:128,429,020...128,430,504
|
|
G |
Foxj2 |
forkhead box J2 |
increases expression |
ISO |
Tunicamycin results in increased expression of FOXJ2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:156,047,043...156,073,540
Ensembl chr 4:156,046,969...156,073,518
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXM1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxn4 |
forkhead box N4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXN4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921
|
|
G |
Foxo1 |
forkhead box O1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXO1 mRNA |
CTD |
PMID:36030031 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Frmd4a |
FERM domain containing 4A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FRMD4A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687
|
|
G |
Frzb |
frizzled-related protein |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FRZB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FSCN1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression decreases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of FTH1 mRNA Tunicamycin results in decreased expression of FTH1 protein leonurine inhibits the reaction [Tunicamycin results in decreased expression of FTH1 protein] |
CTD |
PMID:29453283 PMID:38670420 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fuca2 |
alpha-L-fucosidase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FUCA2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776
|
|
G |
Fut1 |
fucosyltransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of FUT1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
|
|
G |
Fv1 |
Friend virus susceptibility 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of C19ORF48P mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:94,730,839...94,736,791
Ensembl chr 1:94,730,606...94,737,594
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FXYD6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
Fzd7 |
frizzled class receptor 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FZD7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G3bp1 |
G3BP stress granule assembly factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of G3BP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of G6PC1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gabarapl1 |
GABA type A receptor associated protein like 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GABARAPL1 mRNA |
CTD |
PMID:22378314 PMID:33545341 |
|
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of GADD45A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of GADD45B mRNA Tunicamycin results in increased expression of GADD45B mRNA |
CTD |
PMID:17127020 PMID:29453283 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
Tunicamycin results in increased expression of GADD45G mRNA |
CTD |
PMID:29453283 PMID:33545341 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gadd45gip1 |
GADD45G interacting protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GADD45GIP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr19:23,320,662...23,323,211
Ensembl chr19:23,320,159...23,323,236
|
|
G |
Gal |
galanin and GMAP prepropeptide |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GAL mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galc |
galactosylceramidase |
increases expression |
ISO |
Tunicamycin results in increased expression of GALC mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
|
|
G |
Galk2 |
galactokinase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GALK2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:113,110,057...113,243,014
Ensembl chr 3:113,110,030...113,233,306
|
|
G |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GALNT18 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:165,593,180...165,904,268
Ensembl chr 1:165,593,187...165,904,268
|
|
G |
Galr2 |
galanin receptor 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GALR2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:101,513,689...101,517,176
Ensembl chr10:101,514,471...101,517,176
|
|
G |
Ganab |
glucosidase II alpha subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of GANAB mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:205,793,910...205,813,704
Ensembl chr 1:205,793,895...205,813,695
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GAP43 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GARS1 mRNA; Tunicamycin results in increased expression of GARS1 protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gas2 |
growth arrest-specific 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GAS2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of GAS2L3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
|
|
G |
Gata2 |
GATA binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GATA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GATD3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gatm |
glycine amidinotransferase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GATM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
|
|
G |
Gcat |
glycine C-acetyltransferase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GCAT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
|
|
G |
Gcc1 |
GRIP and coiled-coil domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GCC1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:57,030,817...57,042,682
Ensembl chr 4:57,032,314...57,042,663
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GCDH mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of GCLC mRNA NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GCLC mRNA] |
CTD |
PMID:22959925 PMID:36586010 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of GCLM mRNA Tunicamycin results in increased expression of GCLM mRNA |
CTD |
PMID:17127020 PMID:29453283 PMID:36586010 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Tunicamycin results in increased expression of GDF15 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf6 |
growth differentiation factor 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of GDF6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:22,996,246...23,012,567
Ensembl chr 5:22,996,246...23,012,567
|
|
G |
Gfod1 |
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GFOD1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GFPT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
|
|
G |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GGA2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:176,552,046...176,585,332
Ensembl chr 1:176,552,046...176,585,361
|
|
G |
Ggact |
gamma-glutamylamine cyclotransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of GGACT mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:99,969,246...99,998,343
Ensembl chr15:99,968,282...99,993,455
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GGH mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Ghitm |
growth hormone inducible transmembrane protein |
increases expression |
ISO |
Tunicamycin results in increased expression of GHITM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
|
|
G |
Gins2 |
GINS complex subunit 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GINS2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
|
|
G |
Gla |
galactosidase, alpha |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLA mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Glcci1 |
glucocorticoid induced 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLCCI1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
|
|
G |
Gldc |
glycine decarboxylase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLDC mRNA |
CTD |
PMID:22378314 PMID:33770205 |
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glrx |
glutaredoxin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLRX mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glrx3 |
glutaredoxin 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of GLRX3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
|
|
G |
Gls |
glutaminase |
increases expression |
ISO |
Tunicamycin results in increased expression of GLS mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GLT8D1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
|
|
G |
Gmeb1 |
glucocorticoid modulatory element binding protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GMEB1 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 5:144,421,151...144,462,448
Ensembl chr 5:144,420,555...144,462,602
|
|
G |
Gmppa |
GDP-mannose pyrophosphorylase A |
increases expression |
ISO |
Tunicamycin results in increased expression of GMPPA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
|
|
G |
Gmppb |
GDP-mannose pyrophosphorylase B |
increases expression |
ISO |
Tunicamycin results in increased expression of GMPPB mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:108,737,429...108,740,437
Ensembl chr 8:108,693,060...108,767,286
|
|
G |
Gmps |
guanine monophosphate synthase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GMPS mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
|
|
G |
Gnas |
GNAS complex locus |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNAS mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnb1 |
G protein subunit beta 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNB1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
|
|
G |
Gng12 |
G protein subunit gamma 12 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNG12 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
|
|
G |
Gng2 |
G protein subunit gamma 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNG2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,316,059...4,417,183
|
|
G |
Gng4 |
G protein subunit gamma 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNG4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
|
|
G |
Gngt1 |
G protein subunit gamma transducin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GNGT1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:32,006,267...32,009,252
Ensembl chr 4:32,006,267...32,009,252
|
|
G |
Gngt2 |
G protein subunit gamma transducin 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNGT2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:80,776,003...80,784,235
|
|
G |
Gnl3l |
G protein nucleolar 3 like |
increases expression |
ISO |
Tunicamycin results in increased expression of GNL3L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:19,961,277...19,994,454
Ensembl chr X:19,958,603...19,994,508
|
|
G |
Gnptg |
N-acetylglucosamine-1-phosphate transferase subunit gamma |
increases expression |
ISO |
Tunicamycin results in increased expression of GNPTG mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:14,252,186...14,257,128
Ensembl chr10:14,251,136...14,257,096
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNRHR mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
increases expression |
ISO |
Tunicamycin results in increased expression of GNS mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Golga2 |
golgin A2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLGA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:15,583,862...15,604,279
Ensembl chr 3:15,584,039...15,604,279
|
|
G |
Golga3 |
golgin A3 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLGA3 mRNA |
| |